LTE-WiFi Carrier Aggregation for Future 5G Systems: A Feasibility Study and Research Challenges

Rasha Al-Khansa,H. Artail,David Manuel Gutiérrez Estévez

DOI: https://doi.org/10.1016/j.procs.2014.07.068

Abstract:

What problem does this paper attempt to address?

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

Maria Lisa Dentici,Marcello Niceta,Francesca Romana Lepri,Cecilia Mancini,Manuela Priolo,Adeline Alice Bonnard,Camilla Cappelletti,Chiara Leoni,Andrea Ciolfi,Simone Pizzi,Viviana Cordeddu,Cesare Rossi,Marco Ferilli,Mafalda Mucciolo,Vito Luigi Colona,Christine Fauth,Melissa Bellini,Giacomo Biasucci,Lorenzo Sinibaldi,Silvana Briuglia,Andrea Gazzin,Diana Carli,Luigi Memo,Eva Trevisson,Concetta Schiavariello,Maria Luca,Antonio Novelli,Caroline Michot,Anne Sweertvaegher,David Germanaud,Emanuela Scarano,Alessandro De Luca,Giuseppe Zampino,Martin Zenker,Alessandro Mussa,Bruno Dallapiccola,Helene Cavé,Maria Cristina Digilio,Marco Tartaglia

DOI: https://doi.org/10.1038/s41431-024-01642-7

Abstract:Pathogenic, largely truncating variants in the ETS2 repressor factor (ERF) gene, encoding a transcriptional regulator negatively controlling RAS-MAPK signaling, have been associated with syndromic craniosynostosis involving various cranial sutures and Chitayat syndrome, an ultrarare condition with respiratory distress, skeletal anomalies, and facial dysmorphism. Recently, a single patient with craniosynostosis and a phenotype resembling Noonan syndrome (NS), the most common disorder among the RASopathies, was reported to carry a de novo loss-of-function variant in ERF. Here, we clinically profile 26 individuals from 15 unrelated families carrying different germline heterozygous variants in ERF and showing a phenotype reminiscent of NS. The majority of subjects presented with a variable degree of global developmental and/or language delay. Their shared facial features included absolute/relative macrocephaly, high forehead, hypertelorism, palpebral ptosis, wide nasal bridge, and low-set/posteriorly angulated ears. Stature was below the 3rd centile in two-third of the individuals, while no subject showed typical NS cardiac involvement. Notably, craniosynostosis was documented only in three unrelated individuals, while a dolichocephalic aspect of the skull in absence of any other evidence supporting a premature closing of sutures was observed in other 10 subjects. Unilateral Wilms tumor was diagnosed in one individual. Most cases were familial, indicating an overall low impact on fitness. Variants were nonsense and frameshift changes, supporting ERF haploinsufficiency. These findings provide evidence that heterozygous loss-of-function variants in ERF cause a "RASopathy" resembling NS with or without craniosynostosis, and allow a first dissection of the molecular circuits contributing to MAPK signaling pleiotropy.
[An infant with premature closure of cranial sutures due to variant of ERF gene and a literature review]

Jin Wang,Dan Wang,Lingkong Zeng,Shi Wang

DOI: https://doi.org/10.3760/cma.j.cn511374-20220815-00548

2023-08-10

Abstract:Objective: To analyze the clinical and genetic characteristics of an infant with craniosynostosis. Methods: An infant who was admitted to Wuhan Children's Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology in April 2021 due to widening of the lateral ventricles for over a month was selected as the study subject. Clinical data of the patient was collected. Peripheral blood samples were collected from the infant and her parents for chromosomal karyotyping and whole exome sequencing. Candidate variant was verified by Sanger sequencing and bioinformatic analysis. Relevant literature was retrieved from the PubMed, Wanfang and CNKI databases (up to December 2021) by using key words including ERF gene, craniosynostosis, ERF mutation, craniosynostosis and ERF-related craniosynostosis. Results: The infant, a 1-month-and-16-day-old female, was found to have sagittal synostosis by cranial X-ray radiography. Genetic testing revealed that she has harbored a heterozygous c.787C>T (p.Q263*) variant of the ERF gene, which was not found in either parent. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was predicted as pathogenic (PVS1+PS2+PM2_Supporting). In total 63 relevant cases were retrieved from the database, and a total of 64 individuals were analyzed by genetic testing. Most of the cases were sporadic and males. Multiple cranial sutures (including at least two of the sagittal suture, coronal suture, lambdoid suture, and frontal suture) were involved in 45.45% of the cases, and those with sagittal suture closure only have accounted for 20.00%. The main clinical manifestations have included hypertelorism, exophthalmos, development delay, malar dysplasia, etc. Chiari type 1 malformation may present in some patients. Variants of the ERF gene have mainly included splicing and deletional variants, and there was a strong genetic heterogeneity among the infants and their pedigrees. Conclusion: The c.787C>T (p.Q263*) variant of the ERF gene probably underlay the craniosynostosis of this infant. Above finding has enriched the phenotype ~ genotype spectrum of the ERF gene.
De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

Andrew T Timberlake,Stephen McGee,Garrett Allington,Emre Kiziltug,Erin M Wolfe,Amy L Stiegler,Titus J Boggon,May Sanyoura,Michelle Morrow,Tara L Wenger,Erica M Fernandes,Oana Caluseriu,John A Persing,Sheng Chih Jin,Richard P Lifton,Kristopher T Kahle,Paul Kruszka

DOI: https://doi.org/10.1016/j.ajhg.2023.03.017

2023-05-04

Abstract:Craniosynostosis (CS) is the most common congenital cranial anomaly. Several Mendelian forms of syndromic CS are well described, but a genetic etiology remains elusive in a substantial fraction of probands. Analysis of exome sequence data from 526 proband-parent trios with syndromic CS identified a marked excess (observed 98, expected 33, p = 4.83 × 10-20) of damaging de novo variants (DNVs) in genes highly intolerant to loss-of-function variation (probability of LoF intolerance > 0.9). 30 probands harbored damaging DNVs in 21 genes that were not previously implicated in CS but are involved in chromatin modification and remodeling (4.7-fold enrichment, p = 1.1 × 10-11). 17 genes had multiple damaging DNVs, and 13 genes (CDK13, NFIX, ADNP, KMT5B, SON, ARID1B, CASK, CHD7, MED13L, PSMD12, POLR2A, CHD3, and SETBP1) surpassed thresholds for genome-wide significance. A recurrent gain-of-function DNV in the retinoic acid receptor alpha (RARA; c.865G>A [p.Gly289Arg]) was identified in two probands with similar CS phenotypes. CS risk genes overlap with those identified for autism and other neurodevelopmental disorders, are highly expressed in cranial neural crest cells, and converge in networks that regulate chromatin modification, gene transcription, and osteoblast differentiation. Our results identify several CS loci and have major implications for genetic testing and counseling.
Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis

Saïd C. Azoury,Sashank Reddy,Vivek Shukla,Chu-Xia Deng

DOI: https://doi.org/10.7150/ijbs.22373

2017-01-01

International Journal of Biological Sciences

Abstract:Craniosynostosis results from the premature fusion of cranial sutures, with an incidence of 1 in 2,100-2,500 live births.The majority of cases are non-syndromic and involve single suture fusion, whereas syndromic cases often involve complex multiple suture fusion.The fibroblast growth factor receptor 2 (FGFR2) gene is perhaps the most extensively studied gene that is mutated in various craniosynostotic syndromes including Crouzon, Apert, Pfeiffer, Antley-Bixler, Beare-Stevenson cutis gyrata, Jackson-Weiss, Bent Bone Dysplasia, and Seathre-Chotzen-like syndromes.The majority of these mutations are missense mutations that result in constitutive activation of the receptor and downstream molecular pathways.Treatment involves a multidisciplinary approach with ultimate surgical fixation of the cranial deformity to prevent further sequelae.Understanding the molecular mechanisms has allowed for the investigation of different therapeutic agents that can potentially be used to prevent the disorders.Further research efforts are need to better understand screening and effective methods of early intervention and prevention.Herein, the authors provide a comprehensive update on FGFR2-related syndromic craniosynostosis.
Dosage‐dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses

Heather A. Richbourg,Marta Vidal‐García,Katherine A. Brakora,Jay Devine,Risa Takenaka,Nathan M. Young,Siew‐Ging Gong,Amanda Neves,Benedikt Hallgrímsson,Ralph S. Marcucio

DOI: https://doi.org/10.1002/ar.25398

2024-02-27

The Anatomical Record

Abstract:Craniosynostosis is a common yet complex birth defect, characterized by premature fusion of the cranial sutures that can be syndromic or nonsyndromic. With over 180 syndromic associations, reaching genetic diagnoses and understanding variations in underlying cellular mechanisms remains a challenge. Variants of FGFR2 are highly associated with craniosynostosis and warrant further investigation. Using the missense mutation FGFR2W290R, an effective mouse model of Crouzon syndrome, craniofacial features were analyzed using geometric morphometrics across developmental time (E10.5—adulthood, n = 665 total). Given the interrelationship between the cranial vault and basicranium in craniosynostosis patients, the basicranium and synchondroses were analyzed in perinates. Embryonic time points showed minimal significant shape differences. However, hetero‐ and homozygous mutant perinates and adults showed significant differences in shape and size of the cranial vault, face, and basicranium, which were associated with cranial doming and shortening of the basicranium and skull. Although there were also significant shape and size differences associated with the basicranial bones and clear reductions in basicranial ossification in cleared whole‐mount samples, there were no significant alterations in chondrocyte cell shape, size, or orientation along the spheno‐occipital synchondrosis. Finally, shape differences in the cranial vault and basicranium were interrelated at perinatal stages. These results point toward the possibility that facial shape phenotypes in craniosynostosis may result in part from pleiotropic effects of the causative mutations rather than only from the secondary consequences of the sutural defects, indicating a novel direction of research that may shed light on the etiology of the broad changes in craniofacial morphology observed in craniosynostosis syndromes.

anatomy & morphology
Noonan syndrome‐like phenotype associated with an ERF frameshift variant

Yasuhiro Hirano,Yukiko Kuroda,Yumi Enomoto,Takuya Naruto,Koji Muroya,Kenji Kurosawa

DOI: https://doi.org/10.1002/ajmg.a.63652

2024-05-15

American Journal of Medical Genetics Part A

Abstract:Noonan syndrome is a so‐called "RASopathy," that is characterized by short stature, distinctive facial features, congenital heart defects, and developmental delay. Of individuals with a clinical diagnosis of Noonan syndrome, 80%–90% have pathogenic variants in the known genes implicated in the disorder, but the molecular mechanism is unknown in the remaining cases. Heterozygous pathogenic variants of ETS2 repressor factor (ERF), which functions as a repressor in the RAS/MAPK signaling pathway, cause syndromic craniosynostosis. Here, we report an ERF frameshift variant cosegregating with a Noonan syndrome‐like phenotype in a family. The proband was a 3‐year‐old female who presented with dysmorphic facial features, including proptosis, hypertelorism, slightly down slanted palpebral fissures, low‐set posteriorly rotated ears, depressed nasal bridge, short stature, and developmental delay. Exome sequencing of the proband identified a heterozygous ERF variant [NM_006494.4: c.185del p.(Glu62Glyfs*15)]. Her mother and sister showed a similar phenotype and had the same heterozygous ERF variant. A large proportion of the previously reported patients with syndromic craniosynostosis and pathogenic ERF variants also showed characteristic features that overlap with those of Noonan syndrome. The present finding supports an association between heterozygous ERF variants and a Noonan syndrome‐like phenotype.

genetics & heredity
Expanding the phenotypic spectrum of ARCN1-related syndrome

Alyssa L Ritter,Jessica Gold,Hiroshi Hayashi,Amanda M Ackermann,Stephanie Hanke,Cara Skraban,Sanmati Cuddapah,Elizabeth Bhoj,Dong Li,Yukiko Kuroda,Jessica Wen,Ryojun Takeda,Audrey Bibb,Salima El Chehadeh,Amélie Piton,Jeanine Ohl,Mary K Kukolich,Keisuke Nagasaki,Kohji Kato,Tomoo Ogi,Tricia Bhatti,Pierre Russo,Bryan Krock,Jill R Murrell,Jennifer A Sullivan,Vandana Shashi,Nicholas Stong,Hakon Hakonarson,Kentaro Sawano,Erin Torti,Rebecca Willaert,Yue Si,William Ross Wilcox,Katrine Verena Wirgenes,Kristian Thomassen,Katherine Carlotti,Angelika Erwin,Joanna Lazier,Thorsten Marquardt,Miao He,Andrew C Edmondson,Kosuke Izumi,Alyssa L. Ritter,Amanda M. Ackermann,Mary K. Kukolich,Jill R. Murrell,Jennifer A. Sullivan,Andrew C. Edmondson

DOI: https://doi.org/10.1016/j.gim.2022.02.005

IF: 8.864

2022-03-01

Genetics in Medicine

Abstract:PURPOSE: This study aimed to describe the phenotypic and molecular characteristics of ARCN1-related syndrome.METHODS: Patients with ARCN1 variants were identified, and clinician researchers were connected using GeneMatcher and physician referrals. Clinical histories were collected from each patient.RESULTS: In total, we identified 14 cases of ARCN1-related syndrome, (9 pediatrics, and 5 fetal cases from 3 families). The clinical features these newly identified cases were compared to 6 previously reported cases for a total of 20 cases. Intrauterine growth restriction, micrognathia, and short stature were present in all patients. Other common features included prematurity (11/15, 73.3%), developmental delay (10/14, 71.4%), genitourinary malformations in males (6/8, 75%), and microcephaly (12/15, 80%). Novel features of ARCN1-related syndrome included transient liver dysfunction and specific glycosylation abnormalities during illness, giant cell hepatitis, hepatoblastoma, cataracts, and lethal skeletal manifestations. Developmental delay was seen in 73% of patients, but only 3 patients had intellectual disability, which is less common than previously reported.CONCLUSION: ARCN1-related syndrome presents with a wide clinical spectrum ranging from a severe embryonic lethal syndrome to a mild syndrome with intrauterine growth restriction, micrognathia, and short stature without intellectual disability. Patients with ARCN1-related syndrome should be monitored for liver dysfunction during illness, cataracts, and hepatoblastoma. Additional research to further define the phenotypic spectrum and possible genotype-phenotype correlations are required.

genetics & heredity
Mechanism of Disease: Recessive ADAMTSL4 Mutations and Craniosynostosis with Ectopia Lentis

Jonas Gustafson,Maria Bjork,Conny M. A. van Ravenswaaij-Arts,Michael L. Cunningham

DOI: https://doi.org/10.1155/2022/3239260

2022-03-26

Case Reports in Genetics

Abstract:Craniosynostosis, the premature fusion of the calvarial bones, has numerous etiologies. Among them, several involve mutations in genes related to the TGFb signaling pathway, a critical molecular mediator of human development. These TGFb pathway-associated craniosynostosis syndromes include Loeys–Dietz syndrome (LDS) and Shprintzen–Goldberg syndrome (SGS). LDS and SGS have many similarities common to fibrillinopathies, specifically Marfan syndrome (MFS), which is caused by mutations in FBN1. Historically discriminating features of MFS from LDS and SGS are (1) the presence of ectopia lentis (the subluxation/dislocation of the ocular lens) and (2) the absence of craniosynostosis. Curiously, several instances of a seemingly novel syndrome involving only craniosynostosis and ectopia lentis have recently been reported to be caused by recessive mutations in ADAMTSL4, a poorly characterized gene as of yet. Here, we report on two new cases of craniosynostosis with ectopia lentis, each harboring recessive mutations in ADAMTSL4. We also discuss a proposed mechanism for the relationship between ADAMTSL4, FBN1, and TGFb pathway-related syndromes.
Facial skeleton dysmorphology in syndromic craniosynostosis: differences between FGFR2 and no-FGFR2-related syndromes and relationship with skull base and facial sutural patterns

Rosalinda Calandrelli,Fabio Pilato,Luca Massimi,Gabriella D'Apolito,Cesare Colosimo

DOI: https://doi.org/10.1007/s00381-023-05962-9

Abstract:Purpose: To assess the role of FGFR2 mutations and sutural synostotic patterns on facial skeleton dysmorphology in children with syndromic craniosynostosis. Methods: Preoperative high-resolution CT images in 39 infants with syndromic craniosynostosis were evaluated. Patients were divided into infants with and without FGFR2 mutations; each group was split according to synostotic involvement of minor sutures/synchondroses: isolated or combined involvement of middle (MCF) and posterior cranial fossae (PCF). Quantitative analysis of the midface and mandible measures was performed. Each subgroup was compared with a group of age-matched healthy subjects. Results: Twenty-four patients with FGFR2 related syndromes were clustered in 3 subgroups: MCF + PCF (8 patients, 5.4 ± 1.75 months), MCF (8 patients, 3.62 ± 1.68 months), and PCF (8 patients, 2.75 ± 0.46 months). Fifteen no-FGFR2 patients were clustered in 2 subgroups: MCF + PCF (7 patients, 9.42 ± 0.78 months) and PCF (8 patients, 7.37 ± 2.92 months). Both FGFR2 and no-FGFR2 groups with involvement of minor sutures coursing in MCF showed more facial sutural synostoses. Children with minor suture/synchondrosis synostosis of MCF (MCF-PCF and MCF subgroups) showed altered position of glenoid fossa and mandibular inclination ([Formula: see text]), but children in the FGFR2 group had also reduced midfacial depth and maxillary length ([Formula: see text]). Children with minor suture/synchondrosis synostosis of PCF (PCF subgroups) had reduced posterior mandibular height, but those children in the FGFR2 group also showed reduced intergonion distance ([Formula: see text]). Conclusions: In children with syndromic craniosynostosis, both skull base and facial suture synostosis affect facial dysmorphology/hypoplasia. FGFR2 mutations may worsen facial hypoplasia both acting on bone development and causing an earlier premature closure of facial sutures.
Genetic Heterogeneity, Craniofacial Surgical Burden, and Surgical Techniques in Patients With Saethre-Chotzen Syndrome

Dominic J. Romeo,Kaan T. Oral,Benjamin B. Massenburg,Jinggang J. Ng,Meagan Wu,Jonathan H. Sussman,Steven Du,Scott P. Bartlett,Jordan W. Swanson,Jesse A. Taylor

DOI: https://doi.org/10.1097/scs.0000000000010348

2024-07-26

Journal of Craniofacial Surgery

Abstract:Objective: While genotype correlates with phenotype in patients with many forms of syndromic craniosynostosis, the relationship between molecular diagnosis and craniofacial surgical history in patients with Saethre-Chotzen syndrome (SCS) is more variable. This manuscript characterizes that relationship and evaluates operative trends in these patients over the past 3 decades. Methods: Demographic information, molecular diagnosis, and craniofacial surgical history in patients born with SCS between 1989 and 2023 were compared with appropriate statistics, including t tests and analysis of variance. Results: Thirty-five patients with SCS were included, and there was no difference in total craniofacial procedures among those with TWIST1 substitutions (2.1 ± 1.6), duplications (3.0 ± 4.2), insertions (3.5 ± 0.7), or deletions (2.4 ± 1.9; P = 0.97). Cranial expansion rates were also similar across all genetic diagnoses ( P >0.05), and surgical incidence was similar across patients with unicoronal, bicoronal, and multisuture involvement ( P > 0.05). Those with an initial fronto-orbital advancement had a lower incidence of secondary cranial vault procedures compared with those with an initial posterior vault distraction osteogenesis (29% versus 71%, P < 0.05), though this did not control for phenotypic severity. On average, total cranial vault surgical burden (1.35 ± 0.67 versus 1.75 ± 0.46) and cranial expansion surgical burden (1.40 ± 0.68 versus 1.88 ± 0.64) between the fronto-orbital advancement–first and posterior vault distraction osteogenesis–first cohorts were similar ( P = 0.11, P = 0.17, respectively). Conclusion: While SCS is molecularly and phenotypically heterogeneous, genetic diagnosis does not appear associated with rates of craniofacial surgery. Additional prospective study of correlations between genotype, severity of craniofacial manifestations, and treatment algorithms is warranted; but, in the end, it may be that this highly variable form of syndromic craniosynostosis warrants tailored, expectant management.

surgery
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

Lauren Jeffries,Emily K Mis,Kirsty McWalter,Sandra Donkervoort,Nina N Brodsky,Jean-Marie Carpier,Weizhen Ji,Cristian Ionita,Bhaskar Roy,Jon S Morrow,Armine Darbinyan,Krishna Iyer,Ritu B Aul,Siddharth Banka,Katherine R Chao,Laura Cobbold,Stacey Cohen,Helena M Custodio,Margaret Drummond-Borg,Frances Elmslie,Erika Finanger,Bryan E Hainline,Ingo Helbig,Stacy Hewson,Ying Hu,Adam Jackson,Dragana Josifova,Monica Konstantino,Meganne E Leach,Bryan Mak,David McCormick,Elisabeth McGee,Stanley Nelson,Joanne Nguyen,Kimberly Nugent,Lucy Ortega,Howard P Goodkin,Elizabeth Roeder,Sani Roy,Katie Sapp,Dimah Saade,Sanjay M Sisodiya,Karen Stals,Shelley Towner,William Wilson,Deciphering Developmental Disorders,Genomics England Research Consortium,Undiagnosed Disease Network,Mustafa K Khokha,Carsten G Bönnemann,Carrie L Lucas,Saquib A Lakhani

DOI: https://doi.org/10.1016/j.gim.2023.101023

Abstract:Purpose: We sought to delineate a multisystem disorder caused by recessive cysteine-rich with epidermal growth factor-like domains 1 (CRELD1) gene variants. Methods: The impact of CRELD1 variants was characterized through an international collaboration utilizing next-generation DNA sequencing, gene knockdown, and protein overexpression in Xenopus tropicalis, and in vitro analysis of patient immune cells. Results: Biallelic variants in CRELD1 were found in 18 participants from 14 families. Affected individuals displayed an array of phenotypes involving developmental delay, early-onset epilepsy, and hypotonia, with about half demonstrating cardiac arrhythmias and some experiencing recurrent infections. Most harbored a frameshift in trans with a missense allele, with 1 recurrent variant, p.(Cys192Tyr), identified in 10 families. X tropicalis tadpoles with creld1 knockdown displayed developmental defects along with increased susceptibility to induced seizures compared with controls. Additionally, human CRELD1 harboring missense variants from affected individuals had reduced protein function, indicated by a diminished ability to induce craniofacial defects when overexpressed in X tropicalis. Finally, baseline analyses of peripheral blood mononuclear cells showed similar proportions of immune cell subtypes in patients compared with healthy donors. Conclusion: This patient cohort, combined with experimental data, provide evidence of a multisystem clinical syndrome mediated by recessive variants in CRELD1.
Mutations in the Interleukin Receptor IL11RA Cause Autosomal Recessive Crouzon-like Craniosynostosis

Katharina Keupp,Yun Li,Ibrahim Vargel,Alexander Hoischen,Rebecca Richardson,Kornelia Neveling,Yasemin Alanay,Elif Uz,Nursel Elcioglu,Martin Rachwalski,Soner Kamaci,Gokhan Tuncbilek,Burcu Akin,Joachim Grotzinger,Ersoy Konas,Emin Mavili,Gerhard Muller-Newen,Hartmut Collmann,Tony Roscioli,Michael F. Buckley,Gokhan Yigit,Christian Gilissen,Wolfram Kress,Joris Veltman,Matthias Hammerschmidt,Nurten A. Akarsu,Bernd Wollnik

DOI: https://doi.org/10.1002/mgg3.28

2013-01-01

Molecular Genetics & Genomic Medicine

Abstract:We have characterized a novel autosomal recessive Crouzon‐like craniosynostosis syndrome in a 12‐affected member family from Antakya, Turkey, the presenting features of which include: multiple suture synostosis, midface hypoplasia, variable degree of exophthalmos, relative prognathism, a beaked nose, and conductive hearing loss. Homozygosity mapping followed by targeted next‐generation sequencing identified a c.479+6T>G mutation in the interleukin 11 receptor alpha gene (IL11RA) on chromosome 9p21. This donor splice‐site mutation leads to a high percentage of aberrant IL11RA mRNA transcripts in an affected individual and altered mRNA splicing determined by in vitro exon trapping. An extended IL11RA mutation screen was performed in a cohort of 79 patients with an initial clinical diagnosis of Crouzon syndrome, pansynostosis, or unclassified syndromic craniosynostosis. We identified mutations segregating with the disease in five families: a German patient of Turkish origin and a Turkish family with three affected sibs all of whom were homozygous for the previously identified IL11RA c.479+6T>G mutation; a family with pansynostosis with compound heterozygous missense mutations, p.Pro200Thr and p.Arg237Pro; and two further Turkish families with Crouzon‐like syndrome carrying the homozygous nonsense mutations p.Tyr232* and p.Arg292*. Using transient coexpression in HEK293T and COS7 cells, we demonstrated dramatically reduced IL11‐mediated STAT3 phosphorylation for all mutations. Immunofluorescence analysis of mouse Il11ra demonstrated specific protein expression in cranial mesenchyme which was localized around the coronal suture tips and in the lambdoidal suture. In situ hybridization analysis of adult zebrafish also detected zfil11ra expression in the coronal suture between the overlapping frontal and parietal plates. This study demonstrates that mutations in the IL11RA gene cause an autosomal recessive Crouzon‐like craniosynostosis.
Craniosynostosis, inner ear, and renal anomalies in a child with complete loss of SPRY1 (sprouty homolog 1) function

Rebecca S Tooze,Eduardo Calpena,Stephen R F Twigg,Felice D'Arco,Genomics England Research Consortium,Emma L Wakeling,Andrew O M Wilkie,J C Ambrose,P Arumugam,R Bevers,M Bleda,F Boardman-Pretty,C R Boustred,H Brittain,M A Brown,M J Caulfield,G C Chan,A Giess,J N Griffin,A Hamblin,S Henderson,T J P Hubbard,R Jackson,L J Jones,D Kasperaviciute,M Kayikci,A Kousathanas,L Lahnstein,S E Leigh,I U S Leong,F J Lopez,F Maleady-Crowe,M McEntagart,F Minneci,J Mitchell,L Moutsianas,M Mueller,N Murugaesu,A C Need,P O'Donovan,C A Odhams,C Patch,D Perez-Gil,M B Pereira,J Pullinger,T Rahim,A Rendon,T Rogers,K Savage,K Sawant,R H Scott,A Siddiq,A Sieghart,S C Smith,A Sosinsky,A Stuckey,M Tanguy,A L Taylor Tavares,E R A Thomas,S R Thompson,A Tucci,M J Welland,E Williams,K Witkowska,S M Wood,M Zarowiecki

DOI: https://doi.org/10.1136/jmg-2022-108946

Abstract:Introduction: SPRY1 encodes protein sprouty homolog 1 (Spry-1), a negative regulator of receptor tyrosine kinase signalling. Null mutant mice display kidney/urinary tract abnormalities and altered size of the skull; complete loss-of-function of Spry-1 in humans has not been reported. Methods: Analysis of whole-genome sequencing data from individuals with craniosynostosis enrolled in the 100,000 Genomes Project identified a likely pathogenic variant within SPRY1. Reverse-transcriptase PCR and western blot analysis were used to investigate the effect of the variant on SPRY1 mRNA and protein, in lymphoblastoid cell lines from the patient and both parents. Results: A nonsense variant in SPRY1, encoding p.(Leu27*), was confirmed to be heterozygous in the unaffected parents and homozygous in the child. The child's phenotype, which included sagittal craniosynostosis, subcutaneous cystic lesions overlying the lambdoid sutures, hearing loss associated with bilateral cochlear and vestibular dysplasia and a unilateral renal cyst, overlapped the features reported in Spry1-/- null mice. Functional studies supported escape from nonsense-mediated decay, but western blot analysis demonstrated complete absence of full-length protein in the affected child and a marked reduction in both parents. Conclusion: This is the first report of complete loss of Spry-1 function in humans, associated with abnormalities of the cranial sutures, inner ear, and kidneys.
The phenotype of MEGF8-related Carpenter syndrome (CRPT2) is refined through the identification of eight new patients

Laura M. Watts,Marta Bertoli,Tania Attie-Bitach,Natalie Roux,Antonio Rausell,Cate R. Paschal,Jessica L. Zambonin,Cynthia J. Curry,Blanche Martin,Rebecca S. Tooze,Lara Hawkes,Usha Kini,Stephen R. F. Twigg,Andrew O. M. Wilkie

DOI: https://doi.org/10.1038/s41431-024-01624-9

2024-05-18

European Journal of Human Genetics

Abstract:Carpenter syndrome (CRPTS) is a rare autosomal recessive condition caused by biallelic variants in genes that encode negative regulators of hedgehog signalling ( RAB23 [CRPT1] or, more rarely, MEGF8 [CRPT2]), and is characterised by craniosynostosis, polysyndactyly, and other congenital abnormalities. We describe a further six families comprising eight individuals with MEGF8 -associated CRPT2, increasing the total number of reported cases to fifteen, and refine the phenotype of CRPT2 compared to CRPT1. The core features of craniosynostosis, polysyndactyly and (in males) cryptorchidism are almost universal in both CRPT1 and CRPT2. However, laterality defects are present in nearly half of those with MEGF8 -associated CRPT2, but are rare in RAB23 -associated CRPT1. Craniosynostosis in CRPT2 commonly involves a single midline suture in comparison to the multi-suture craniosynostosis characteristic of CRPT1. No patient to date has carried two MEGF8 gene alterations that are both predicted to lead to complete loss-of-function, suggesting that a variable degree of residual MEGF8 activity may be essential for viability and potentially contributing to variable phenotypic severity. These data refine the phenotypic spectrum of CRPT2 in comparison to CRPT1 and more than double the number of likely pathogenic MEGF8 variants in this rare disorder.

genetics & heredity,biochemistry & molecular biology
Microdeletions involving chromosomes 12 and 22 associated with syndromic Duane retraction syndrome

Khaled K Abu-Amero,Altaf A Kondkar,Darren T Oystreck,Arif O Khan,Thomas M Bosley

DOI: https://doi.org/10.3109/13816810.2014.921317

Abstract:Background: Duane retraction syndrome (DRS) is the most common of the congenital cranial dysinnervation disorders (CCDDs). CCDDs can be monogenic or chromosomal in origin. Identification of the genetic cause(s) in patients and families with DRS facilitates definitive diagnosis and provides insights into these developmental errors. Materials and methods: This study described a young girl with DRS on the left and several additional developmental abnormalities. Clinical examination including neuroimaging, sequencing of candidate genes associated with DRS, and array comparative genomic hybridization (array CGH) were performed. Results: The proband had unilateral DRS type 3 on the left with somewhat low-set ears, mild motor delay with normal intelligence, and an asymmetric neck without a palpable right sternocleidomastoid muscle. Spine X-rays revealed a Klippel-Feil syndrome (KFS) and an MRI showed a webbed neck. She also had spina bifida at C8-T1 and a submucosal cleft palate. The parents of the proband were related with no other family member affected similarly. Sequencing of SALL4, CHN1, HOXA1, and TUBB3 did not show any mutation. Array CGH revealed de novo deletions of 21 Kb on chromosome 12q24.31 and 11 Kb on chromosome 22q13.31, each encompassing only one gene, ring finger protein 34, E3 ubiquitin protein ligase (RNF34) and peroxisome proliferator-activated receptor alpha (PPARA) respectively. Conclusions: This patient presents an unusual phenotype associated with a unique combination of two chromosomal microdeletions.
The Craniofacial Collaboration UK: Developmental Outcomes in 7- and 10-Year-Old Children With Sagittal Synostosis

Samuel Lloyd-White,Rosanna Samuel,Laura Edwards-Bailey,Katie Piggott,Sabrina Blighe,Amber Bassi,Matthew Hotton,Jo Horton,David Johnson,Christopher Parks,Anna Kearney

DOI: https://doi.org/10.1097/scs.0000000000010163

2024-07-01

Journal of Craniofacial Surgery

Abstract:The Craniofacial Collaboration UK (CC-UK) protocol is a shared agreement across the 4 UK Highly Specialist Craniofacial Centres (HSCCs) to conduct robust neurodevelopmental and psychosocial clinical screening for children with craniosynostosis. This agreement allows for the analysis of outcomes of a homogenous sample of children with single suture craniosynostosis (SSC), a frequent limitation of the existing research. The current study is the latest analysis of CC-UK data on behavioral, cognitive, and psychosocial outcomes. The focus of this analysis is 7- and 10-year-olds with nonsyndromic sagittal synostosis (SS) who have undergone primary corrective surgery and completed routine clinical screening at 1 of the 4 HSCCs since the introduction of the CC-UK protocol. Due to changes in clinical pathways, only data from 3 HSCCs is included to preserve homogeneity. Results show that the majority of children with SS fall within the average range across behavioral and neurodevelopmental domains. A notable exception was a task involving perceptual reasoning and visuomotor skills (Block Design). Although this difference was small and the mean score remained within the average range, it suggests some increased risk of subtle difficulty with such skills for children with SS. Across other measures, there was no consistent evidence of any significantly increased risk of poorer outcomes, in line with findings of previous CC-UK papers. Understanding the psychological phenotype of SS is a key research priority for parents and clinicians, and the current study is another step toward achieving this goal.

surgery
Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype–phenotype relationship in RASopathies

Jihoon G. Yoon,Jung Woo Yu,Kyu Won Shim,Yong Oock Kim,Min Goo Lee

DOI: https://doi.org/10.1111/cge.14539

2024-04-30

Clinical Genetics

Abstract:RASopathies, caused by variants in Ras/MAPK pathways, include newly associated MAP4K4 gene disorders. This study details a Korean boy with a de novo MAP4K4 variant, presenting craniofacial dysmorphism, developmental delays, and syndromic craniosynostosis, expanding the known phenotypic spectrum and underscoring MAP4K4's impact on cranial suture development. RASopathies represent a distinct class of neurodevelopmental syndromes caused by germline variants in the Ras/MAPK pathways. Recently, a novel disease‐gene association was implicated in MAPK kinase kinase kinase 4 (MAP4K4), which regulates the upstream signals of the MAPK pathways. However, to our knowledge, only two studies have reported the genotype–phenotype relationships in the MAP4K4‐related disorder. This study reports on a Korean boy harboring a novel de novo missense variant in MAP4K4 (NM_001242559:c.569G>T, p.Gly190Val), revealed by trio exome sequencing, and located in the hotspot of the protein kinase domain. The patient exhibited various clinical features, including craniofacial dysmorphism, language delay, congenital heart defects, genitourinary anomalies, and sagittal craniosynostosis. Our study expands the phenotypic association of the MAP4K4‐related disorder to include syndromic craniosynostosis, thereby providing further insights into the role of the RAS/MAPK pathways in the development of premature fusion of calvarial sutures.

genetics & heredity
The value of genome-wide analysis in craniosynostosis

Alexandra Topa,Anna Rohlin,André Fehr,Lovisa Lovmar,Göran Stenman,Peter Tarnow,Giovanni Maltese,Madiha Bhatti-Søfteland,Lars Kölby

DOI: https://doi.org/10.3389/fgene.2023.1322462

IF: 3.7

2024-01-23

Frontiers in Genetics

Abstract:Background: This study assessed the diagnostic yield of high-throughput sequencing methods in a cohort of craniosynostosis (CS) patients not presenting causal variants identified through previous targeted analysis. Methods: Whole-genome or whole-exome sequencing (WGS/WES) was performed in a cohort of 59 patients (from 57 families) assessed by retrospective phenotyping as having syndromic or nonsyndromic CS. Results: A syndromic form was identified in 51% of the unrelated cases. A genetic cause was identified in 38% of syndromic cases, with novel variants detected in FGFR2 (a rare Alu insertion), TWIST1, TCF12, KIAA0586, HDAC9, FOXP1 , and NSD2 . Additionally, we report two patients with rare recurrent variants in KAT6A and YY1 as well as two patients with structural genomic aberrations: one with a 22q13 duplication and one with a complex rearrangement involving chromosome 2 (2p25 duplication including SOX11 and deletion of 2q22). Moreover, we identified potentially relevant variants in 87% of the remaining families with no previously detected causal variants, including novel variants in ADAMTSL4, ASH1L, ATRX, C2CD3, CHD5, ERF, H4C5, IFT122, IFT140, KDM6B, KMT2D, LTBP1, MAP3K7, NOTCH2, NSD1, SOS1, SPRY1, POLR2A, PRRX1, RECQL4, TAB2, TAOK1, TET3, TGFBR1, TCF20 , and ZBTB20 . Conclusion: These results confirm WGS/WES as a powerful diagnostic tool capable of either targeted in silico or broad genomic analysis depending on phenotypic presentation (e.g., classical or unusual forms of syndromic CS).

genetics & heredity
The effects of cladribine and fludarabine on DNA methylation in K562 cells.

D. Wyczechowska,K. Fabianowska-Majewska

DOI: https://doi.org/10.1016/S0006-2952(02)01486-7

IF: 6.1

2003-01-15

Biochemical Pharmacology

Abstract:
Novel de novo missense mutation in the interferon regulatory factor 6 gene in an Italian infant with IRF6-related disorder

Ingrid Anne Mandy Schierz,Salvatore Amoroso,Vincenzo Antona,Mario Giuffrè,Ettore Piro,Gregorio Serra,Giovanni Corsello

DOI: https://doi.org/10.1186/s13052-022-01330-6

2022-07-29

Abstract:Background: Congenital maxillomandibular syngnathia is a rare craniofacial anomaly leading to difficulties in feeding, breathing and ability to thrive. The fusion may consist of soft tissue union (synechiae) to hard tissue union. Isolated cases of maxillomandibular fusion are extremely rare, it is most often syndromic in etiology. Case presentation: Clinical management of a female newborn with oromaxillofacial abnormities (synechiae, cleft palate, craniofacial dysmorphisms, dental anomaly) and extraoral malformations (skinfold overlying the nails of both halluces, syndactyly, abnormal external genitalia) is presented. The associated malformations addressed to molecular genetic investigations revealing an interferon regulatory factor 6 (IRF6)-related disorder (van der Woude syndrome/popliteal pterygium syndrome). A novel de novo heterozygous mutation in exon 4 of IRF6 gene on chromosome 1q32.2, precisely c.262A > G (p.Asn88Asp), was found. Similarities are discussed with known asparagine missense mutations in the same codon, which may alter IRF6 gene function by reduced DNA-binding ability. A concomitant maternal Xp11.22 duplication involving two microRNA genes could contribute to possible epigenetic effects. Conclusions: Our reported case carrying a novel mutation can contribute to expand understandings of molecular mechanisms underlying synechiae and orofacial clefting and to correct diagnosing of incomplete or overlapping features in IRF6-related disorders. Additional multidisciplinary evaluations to establish the phenotypical extent of the IRF6-related disorder and to address family counseling should not only be focused on the surgical corrections of syngnathia and cleft palate, but also involve comprehensive otolaryngologic, audiologic, logopedic, dental, orthopedic, urological and psychological evaluations.

LTE-WiFi Carrier Aggregation for Future 5G Systems: A Feasibility Study and Research Challenges

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

[An infant with premature closure of cranial sutures due to variant of ERF gene and a literature review]

De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis

Dosage‐dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses

Noonan syndrome‐like phenotype associated with an ERF frameshift variant

Expanding the phenotypic spectrum of ARCN1-related syndrome

Mechanism of Disease: Recessive ADAMTSL4 Mutations and Craniosynostosis with Ectopia Lentis

Facial skeleton dysmorphology in syndromic craniosynostosis: differences between FGFR2 and no-FGFR2-related syndromes and relationship with skull base and facial sutural patterns

Genetic Heterogeneity, Craniofacial Surgical Burden, and Surgical Techniques in Patients With Saethre-Chotzen Syndrome

Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

Mutations in the Interleukin Receptor IL11RA Cause Autosomal Recessive Crouzon-like Craniosynostosis

Craniosynostosis, inner ear, and renal anomalies in a child with complete loss of SPRY1 (sprouty homolog 1) function

The phenotype of MEGF8-related Carpenter syndrome (CRPT2) is refined through the identification of eight new patients

Microdeletions involving chromosomes 12 and 22 associated with syndromic Duane retraction syndrome

The Craniofacial Collaboration UK: Developmental Outcomes in 7- and 10-Year-Old Children With Sagittal Synostosis

Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype–phenotype relationship in RASopathies

The value of genome-wide analysis in craniosynostosis

The effects of cladribine and fludarabine on DNA methylation in K562 cells.

Novel de novo missense mutation in the interferon regulatory factor 6 gene in an Italian infant with IRF6-related disorder